Zhao Wu

This inventor holds 28 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Cell Therapy Technology. Top assignees: Innovative Cellular Therapeutics Holdings, Ltd., Innovative Cellular Therapeutics Co., Ltd., Innovative Cellular Therapeutics, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhao Wu. Retrieved from https://idiyas.com/inventor/zhao-wu-c2sm9gwx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 15)

% Patents Active = 89.3

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 20)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 61(Granted Patents)

Company Filing History:

17 out of 31

Innovative Cellular Therapeutics Holdings, Ltd.

patents

9 out of 11

Innovative Cellular Therapeutics Co., Ltd.

patents

6 out of 15

Innovative Cellular Therapeutics, Inc.

patents

4. 2 out of 2

Sidansai Biotechnology Co., Ltd

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Cell Therapy

Chimeric Antigen Receptor

CAR T Therapy

Immunotherapy

Anti-CD19 Antibody

Nanobody

Immune Tolerance

Modified Cells

Cancer Treatment

Autoimmune Disease

Cell Function Modulation

Lymphocyte Cell Lines

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760117 - Nanobody Target MSLN and Uses in Chimeric Antigen Receptor Cell Therapy (2026-10-13),

2. 12708672 - Vaccine and Uses thereof in Cell Therapy (2026-08-18),

3. 12702708 - Presenting cell and use thereof in cell therapy (2026-08-11),

4. 12297267 - Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor (2025-05-13),

5. 12076343 - Engineered safety in cell therapy (2024-09-03),

6. 11970548 - Nanobody target GCC and uses in chimeric antigen receptor cell therapy (2024-04-30),

7. 11932873 - Reducing immune tolerance induced by PD-L1 (2024-03-19),

8. 11932700 - Use of chimeric antigen receptor modified cells to treat cancer (2024-03-19),

9. 11866494 - CAR T therapy through uses of co-stimulation (2024-01-09),

10. 11773384 - Chimeric antigen receptor (CAR) and T cell receptor (TCR) modified T cells (2023-10-03),

11. 11701385 - Modulation of cell function for immunotherapy (2023-07-18),

12. 11690874 - Use of chimeric antigen receptor modified cells to treat autoimmune disease (2023-07-04),

13. 11633427 - Vaccine and uses thereof in cell therapy (2023-04-25),

14. 11566223 - Chimeric antigen receptor cell preparation and uses thereof (2023-01-31),

15. 11364289 - Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor (2022-06-21),

Title: Inventor Zhao Wu - Revolutionizing Technology in Shanghai

Introduction: Zhao Wu is a visionary inventor based in Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Zhao Wu holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his commitment to pushing the boundaries of what is possible in the tech industry.

Career Highlights: With a career spanning over two decades, Zhao Wu has worked with leading tech companies in Shanghai, spearheading research and development projects that have led to significant advancements in various sectors.

Collaborations: Zhao Wu has collaborated with top research institutions and universities in China, fostering a culture of innovation and knowledge-sharing to drive progress in the tech field. His collaborative efforts have resulted in the development of cutting-edge technologies that have the potential to shape the future.

Conclusion: Zhao Wu's relentless pursuit of innovation and his passion for creating technology that makes a difference have solidified his reputation as a pioneering inventor in Shanghai and beyond. His work continues to inspire the next generation of inventors and tech enthusiasts worldwide.

Profile summary based on public USPTO records.